Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Sep 25 - Sep 30
What GLP-1 Users Are Buying Are Buying Heres how GLP-1 influenced behavior is showing up on shelves: Higher demand for protein and fiber: Lean proteins, meat snacks, Greek yogurt, and nutrient-dense options are performing well, while sugary, high-calorie snacks are declining
Additional measures are in place to ensure the consumer's safety
The results of the large cardiovascular event-driven safety trial comparing tirzepatide with dulaglutide in 12,500 participants in the SURPASS-CVOT study are expected in 2024 (78)
Note that outcomes are variable
US$ 24.25
US$ 29.95
US$ 23.97
